RCG offering long-term value after selloff

Morgans Financial Limited

Morgans Financial Limited

A strong FY16 result was somewhat overshadowed by a relatively soft trading update for the first eight weeks of FY17. The competitive pricing pressure which impacted The Athletes Foot (TAF) in July has since eased, while the softness in Hype should normalise as further exclusive products hit stores and delivery delays are resolved. Despite the softer start to the FY, this conservative management team has maintained FY guidance, which speaks volumes in our view. Following the results, our EBITDA forecasts are broadly unchanged (-1%). On a long term view, we see value after the recent sell-off but acknowledge outperformance may be capped until more positive like-for-like sales momentum is visible in Hype and The Athletes Foot. Get our latest update, including the analyst rating: (VIEW LINK)


MORE ON



Stockbroker
Morgans Financial Limited

Morgans is Australia's largest national full-service retail stockbroking and wealth management network with over 240,000 client accounts, 500 authorised representatives and 950 employees operating from offices in all states and territories.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.